{"DataElement":{"publicId":"5358351","version":"1","preferredName":"CLL Leukemia Rai Description Finding Status Indicator","preferredDefinition":"Information related to the status of the laboratory results for Rai staging.","longName":"2189808v1.0:3436461v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2189808","version":"1","preferredName":"CLL Leukemia Rai Description","preferredDefinition":"information related to the Rai stage or description for chronic lymphocytic leukemia.","longName":"CLL_LEUK_RAI_DESC","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2206660","version":"1","preferredName":"CLL Leukemia","preferredDefinition":"The most common type of chronic lymphoid leukemia, and comprises 90% of chronic lymphoid leukemias in the United States.  Morphologically, the neoplastic cells are small, round B-lymphocytes.  The clinical course is indolent, but this type of leukemia is not considered to be curable with available therapy. (WHO, 2001) -- 2003:A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood.  Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present.  Leukemia is usually associated with anemia, fever, hemorrhagic episodes and splenomegaly.  Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia.  Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years. -- 2004","longName":"C3163:C3161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Lymphocytic Leukemia","conceptCode":"C3163","definition":"The most common type of chronic lymphoid leukemia.  It comprises 90% of chronic lymphoid leukemias in the United States.  Morphologically, the neoplastic cells are small, round B-lymphocytes.  This type of leukemia is not considered to be curable with available therapy. (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Leukemia","conceptCode":"C3161","definition":"A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood. Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present. Leukemia is usually associated with anemia, fever, hemorrhagic episodes, and splenomegaly. Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia. Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-FEFE-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2660713","version":"1","preferredName":"Rai Staging System Description ","preferredDefinition":"A staging system for Chronic Lymphocytic Leukemia.  Stage 0: absolute lymphocytosis (>15,000 per cubic millimeter) without adenopathy, hepatosplenomegaly, anemia, or thrombocytopenia; Stage I: absolute lymphocytosis with lymphadenopathy without hepatosple:Description; a statement that represents something in words.","longName":"C20115:C25365","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Rai Staging System","conceptCode":"C20115","definition":"A staging system for Chronic Lymphocytic Leukemia.  Stage 0: absolute lymphocytosis (>15,000 per cubic millimeter) without adenopathy, hepatosplenomegaly, anemia, or thrombocytopenia; Stage I: absolute lymphocytosis with lymphadenopathy without hepatosplenomegaly, anemia, or thrombocytopenia; Stage II: absolute lymphocytosis with either hepatomegaly or splenomegaly, with or without lymphadenopathy; Stage III: absolute lymphocytosis and anemia (hemoglobin <11 g/dL) with or without lymphadenopathy, hepatomegaly, or splenomegaly; Stage IV: absolute lymphocytosis and thrombocytopenia (<100,000 per cubic millimeter) with or without lymphadenopathy, hepatomegaly, splenomegaly, or anemia.  (from OncoLink)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Description","conceptCode":"C25365","definition":"A written or verbal account, representation, statement, or explanation of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"33E73C82-CB3A-5882-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2007-06-27","modifiedBy":"ONEDATA","dateModified":"2007-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E6406F92-0805-4359-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-10-12","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3436461","version":"1","preferredName":"Finding Status Indicator","preferredDefinition":"The result of an examination or inquiry._A condition or state at a particular time._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"3436461v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Not known","valueDescription":"Unknown","ValueMeaning":{"publicId":"2575365","version":"1","preferredName":"Unknown","longName":"2575365","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F372-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BD68EF3A-8494-07E3-E040-BB89AD432E85","beginDate":"2012-04-11","endDate":"2013-03-12","createdBy":"KUMMEROA","dateCreated":"2012-04-11","modifiedBy":"COOPERM","dateModified":"2013-03-12","deletedIndicator":"No"},{"value":"Known","valueDescription":"Known","ValueMeaning":{"publicId":"2934435","version":"1","preferredName":"Known","longName":"2934435","preferredDefinition":"Recognized, familiar, or within the scope of knowledge.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Known","conceptCode":"C80137","definition":"Recognized, familiar, or within the scope of knowledge.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7181A67F-9F52-BB55-E040-BB89AD432FA8","latestVersionIndicator":"Yes","beginDate":"2009-08-19","endDate":null,"createdBy":"SCOTTLO","dateCreated":"2009-08-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BD68EF3A-849E-07E3-E040-BB89AD432E85","beginDate":"2012-04-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-04-11","modifiedBy":"ONEDATA","dateModified":"2012-04-11","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"3371379","version":"1","preferredName":"Unknown","longName":"3371379","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B85BD33E-6B16-07C2-E040-BB89AD430D59","latestVersionIndicator":"Yes","beginDate":"2012-02-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-02-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D7BD97A7-4320-2EE8-E040-BB89AD432C32","beginDate":"2013-03-12","endDate":null,"createdBy":"NYCHM","dateCreated":"2013-03-12","modifiedBy":"ONEDATA","dateModified":"2013-03-12","deletedIndicator":"No"},{"value":"Not applicable","valueDescription":"Not applicable","ValueMeaning":{"publicId":"2581003","version":"1","preferredName":"Not applicable","longName":"2581003v1.00","preferredDefinition":"Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0978-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"CLOHNES","dateModified":"2023-11-09","changeDescription":null,"administrativeNotes":"2023.3.6 Added Alt VM-COG. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F46C20D5-2CDB-328F-E040-BB89AD43753E","beginDate":"2014-03-12","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-03-12","modifiedBy":"ONEDATA","dateModified":"2014-03-12","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3436460","version":"1","preferredName":"Finding Status Indicator","preferredDefinition":"The result of an examination or inquiry.:A condition or state at a particular time.:An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"C61036:C25688:C25180","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Investigation Finding","conceptCode":"C61036","definition":"The result of an examination or inquiry.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Indicator","conceptCode":"C25180","definition":"An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD68EF3A-846D-07E3-E040-BB89AD432E85","latestVersionIndicator":"Yes","beginDate":"2012-04-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-04-11","modifiedBy":"ONEDATA","dateModified":"2012-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD68EF3A-847E-07E3-E040-BB89AD432E85","latestVersionIndicator":"Yes","beginDate":"2012-04-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-04-11","modifiedBy":"CAMPBELB","dateModified":"2015-04-13","changeDescription":".3/12/13mn-due to new form revisions (FN3), PV has changed from \"Not Known\" to \"Unknown\". MC put end date on Not Known & I created \"Unknown\" PV.  Added \"Not applicable\" PV for use on 2116 3/12/14 SLS.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"CLLP_DADX_rai_stage_kn","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What is the status of the Rai","type":"Preferred Question Text","description":"What is the status of the Rai staging finding?","url":null,"context":"NHLBI"},{"name":"Rai stage","type":"Alternate Question Text","description":"Rai stage","url":null,"context":"NHLBI"},{"name":"Rai stage","type":"Application Standard Question Text","description":"Rai stage","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3889A66F-A2B7-1254-E050-BB89AD43173A","latestVersionIndicator":"Yes","beginDate":"2016-07-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-07-26","modifiedBy":"NYCHM","dateModified":"2016-11-22","changeDescription":".11/22/16-released.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}